Navigation Links
aTyr Pharma Raises an Additional $12 Million
Date:7/28/2009

SAN DIEGO, July 28 /PRNewswire/ -- aTyr Pharma announced today that it has raised an additional $12 million to fund its discovery operations and development of its lead candidate. The company is discovering and developing biotherapeutics to treat a wide variety of diseases, including inflammation, autoimmune, hematopoietic and metabolic disorders. Founded in 2006 by Paul Schimmel, a Professor at The Scripps Research Institute and John Clarke of Cardinal Partners, aTyr Pharma's investors provided $12 million in 2007 to build aTyr Pharma's discovery engine and intellectual property. This new investment will be used to expand aTyr Pharma's discovery and preclinical platforms as well as to continue development of the lead drug candidate.

aTyr Pharma's product class is based on a novel group of naturally occurring resected proteins (resectins) from aminoacyl tRNA synthetases. While the large family of aminoacyl tRNA synthetases is universal and essential to protein synthesis in all organisms, resectins of human tRNA synthetases have additional potent cell signaling activities that are vital to normal functioning of humans. When Professor Paul Schimmel, an expert on tRNA synthetases and a successful biotechnology entrepreneur, began discovering the novel functions in this ancient class of proteins he realized that the tRNA synthetase resectins represented a rich source of proteins that had therapeutic potential. According to Jeff Watkins, CEO of aTyr Pharma, "This new financial support validates both the science and strategy of aTyr Pharma. Our strong investor group of Alta Partners, Cardinal Partners, Polaris Ventures and Paul Schimmel has valuable experience in founding and leading many successful biotechnology companies, including Alkermes, Alnylam Pharmaceuticals, Cubist Pharmaceuticals, Momenta Pharmaceuticals and Sirtris Pharmaceuticals. We are pleased to have support from these leading venture ca
'/>"/>

SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 Current Back2Basics long-term drug rehab ... post foot surgery during his first six months of sobriety. ... – twice on one foot, once on the other– which ... my foot a year ago and was prescribed drugs that ... by a friend from home who’d recently completed the program. ...
(Date:7/29/2014)... 29, 2014 Couples rule at Maui's only ... Wailea. This September through November, the focus is on ... to couples of all ages and interests. Best of ... advantage of the Resort's popular Experience More package , ... yearly sale" is in full swing in the award-winning restaurants, ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The Multiple ... organization has announced the appointment of five new members ... the Coalition announced the election of its executive directors. ... 6 Board members and 2 Physician Advisors. These ... MSA Coalition mission of education, support, advocacy and research ...
(Date:7/29/2014)... 2014 Septic tanks have ... This score reflects a buyer's moderate ability to negotiate ... of suppliers, the product's widespread availability and the price-competitive ... Jordan Weinstein. IBISWorld estimates that there are more than ... of supplier options. However, recent demand growth and rising ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Ticketability.com has reduced ... have already been selling at lower prices on the secure ... receive a further discount on tickets that are priced lower ... selection of tickets available at Ticketability.com. , Theatergoers know that ... eager to find Phantom of the Opera tickets for sale ...
Breaking Medicine News(10 mins):Health News:Back2Basics Sober Living Resident Overcomes Obstacle in Early Sobriety 2Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 2Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 4Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 4Health News:Phantom of the Opera Tickets for Sale: Ticketability.com Delights Customers with Phantom of the Opera Theatre Tickets While Seats Last 2
... mouse genetic system co-developed by researchers at the University of ... biologist Hui Zong has isolated the cellular origin for malignant ... oligodendrocyte precursor cells (OPCs) are the point of origin is ... the July 22 issue of the journal Cell . ...
... , THURSDAY, July 7 (HealthDay News) -- The female ancestor ... lived in the vicinity of present-day Britain and Ireland 20,000 ... scientists. It,s likely that climate changes that affected the ... habitats and interbreeding between brown bears and polar bears. This ...
... Identifying a suitable donor for leukemia and lymphoma patients ... now that results of two clinical trials show transplant ... are comparable to fully matched tissue, thanks in large ... special post-transplant chemotherapy. The finding means that nearly ...
... Family doctors are reluctant to disclose identifiable patient ... mostly in an effort to protect patient privacy. A ... Canada Research Chair in Electronic Health Information at the ... Ontario Research Institute recently found that during the peak ...
... Gender may be associated with an increased risk ... knees, according to research being presented at the American ... Diego. "Having articular cartilage lesions ... the knee) is considered a predictor of future osteoarthritis-a ...
... In the largest reported series yet to compare transcervical ... staging and restaging of non-small cell lung cancer (NSCLC), ... research presented at the 14th World Conference on Lung ... the Study of Lung Cancer (IASLC). Diagnostic yield ...
Cached Medicine News:Health News:Cellular origin of deadly brain cancer is identified 2Health News:Cellular origin of deadly brain cancer is identified 3Health News:Female Ancestor of All Living Polar Bears Was Brown 2Health News:Half-matched transplants widen pool of donors for leukemia and lymphoma 2Health News:Half-matched transplants widen pool of donors for leukemia and lymphoma 3Health News:New report explains why physicians are reluctant to share patient data 2
(Date:7/29/2014)... 29, 2014   Health 2.0 announces Bernard ... visionary physicians Eric Topol , Patrick Soon-Shiong , ... Health 2.0 8th Annual Fall Conference this coming Sept. ... year, Health 2.0 is set to host the very first ... session on Consumer Tech & Wearables: Powering Healthy Lifestyles. ...
(Date:7/29/2014)... --   Glide Pharmaceutical Technologies ... an exclusive worldwide licence to an innovative prostate cancer ... University spin-out company.  Under the terms of ... development and commercial milestone payments, and royalties on future ... for additional exclusive licences to FScan diagnostic technologies, for ...
(Date:7/29/2014)... 29, 2014   , ... investigating the efficacy and safety of MSB0010718C in patients with ... rare and aggressive skin cancer lacking effective treatments   ... Phase I clinical trial for the treatment of solid tumors ... Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ...
Breaking Medicine Technology:Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 2Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5
... , WASHINGTON, June 8 Trust for America,s Health ... a new public opinion survey today which finds that ... reform priority, and overwhelmingly support increasing funding for prevention ... , , In the poll, conducted by Greenberg ...
... Usability Gaps in Remote Patient Monitoring Market , ... leading innovator in remote patient monitoring (RPM), announced today ... for the remote monitoring of patients, vital signs by ... currently available monitoring technologies, dramatically simplifying the way in ...
Cached Medicine Technology:New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 2New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 3New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 4New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 5VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers 2VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers 3VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers 4
The Urology C-Arm Table features motorized actuation of height, X-Y, lateral roll and Trendelenburg motions of the tabletop, and is fully accessorized for urologic procedures....
Image Diagnostics' Aspect100U is specifically designed for ease of use and high quality image outcome during urological procedures. Aspect tables benefit from a trim, lightweight design, ensuring a s...
The design of this table top is based on advanced functionality for specific urological requirements. This composite product sets a new standard for urological imaging....
... imaging system that provides clinically ... improved patient care and efficiency.With ... physicians and technologists are now ... detail and more precise definition ...
Medicine Products: